翰宇药业 (300199.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(单季度)(翰宇药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年第三季度2023年第二季度2023年第一季度2022年第四季度2022年第三季度2022年第二季度2022年第一季度
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 76,276,447.05149,055,998.57176,222,802.86173,357,591.16174,434,483.66189,317,300.88167,212,356.18
 营业收入(元) 76,276,447.05149,055,998.57176,222,802.86173,357,591.16174,434,483.66189,317,300.88167,212,356.18
二、营业总成本(元) 206,284,908.84227,647,300.30201,091,127.75292,896,919.29243,091,743.80234,695,174.52153,986,253.73
 营业成本(元) 53,266,404.6843,828,610.3049,589,539.9045,678,170.9833,290,124.1442,926,674.6837,732,421.32
 研发费用(元) 30,308,895.4043,408,846.8044,393,211.4356,244,137.0039,102,374.6541,579,235.1221,750,925.60
 营业税金及附加(元) 1,355,401.234,355,862.072,138,543.256,444,404.983,524,460.953,375,108.033,255,745.45
 销售费用(元) 53,708,586.8370,443,768.6840,763,914.17116,718,536.57111,033,777.60102,641,215.9045,412,434.07
 管理费用(元) 33,776,935.8836,560,265.4635,413,183.9525,896,067.2832,410,629.5023,566,157.2624,583,277.70
 财务费用(元) 33,868,684.8229,049,946.9928,792,735.0541,915,602.4823,730,376.9620,606,783.5321,251,449.59
  其中:利息费用(元) 32,206,621.0927,617,002.3127,907,368.9838,831,030.2022,824,878.5520,712,530.6720,880,968.42
  其中:利息收入(元) 63,226.9250,060.5859,437.7857,950.73130,518.89164,837.58215,362.40
 资产减值损失(元) 5,259,116.14---52,219,545.48-1,787,320.19-513.90
 信用减值损失(元) -3,348,980.71-6,564,248.56-1,766,646.00-28,375,755.76-6,506,483.06-7,644,934.213,035,076.61
三、其他经营收益
 加:公允价值变动收益(元) -8,668,810.4034,914,384.4027,781,417.40-11,727,209.0221,868,699.47-6,168,600.42-73,474,633.62
 加:投资收益(元) -671,114.54-11,993,761.32-263,908.12-19,454,805.64975,284.761,015,967.01-2,802,237.72
  其中:对联营企业和合营企业的投资收益(元) ----7,172,000.29-544,040.13--
 资产处置收益(元) 43,293.09-63,000.401,227,306.0213,531.52--
 其他收益(元) 4,989,589.204,513,585.6119,243,596.097,998,453.785,056,309.866,976,188.505,800,804.37
四、营业利润(元) -132,405,369.01-50,865,497.8420,189,134.88-222,090,884.23-47,249,917.59-47,247,674.05-54,215,401.81
 加:营业外收入(元) 62,605.4730,182.6238,370.31213,646.8567,572.34157,033.372,795,208.25
 减:营业外支出(元) 12,314,275.71-1,713,759.563,305,199.49-22,900.24886,127.11-2,499,764.666,878,694.86
五、利润总额(元) -144,657,039.25-49,121,555.6616,922,305.70-221,854,337.14-48,068,472.36-44,590,876.02-58,298,888.42
 减:所得税费用(元) 2,159,923.604,101,796.92-1,343,030.772,465,776.86814,121.17-3,623,088.6178,165.29
六、净利润(元) -146,816,962.85-53,223,352.5818,265,336.47-224,320,114.00-48,882,593.53-40,967,787.41-58,377,053.71
(一)按经营持续性分类
  持续经营净利润(元) -146,816,962.85-53,223,352.5818,265,336.47-224,320,114.00-48,882,593.53-40,967,787.41-58,377,053.71
(二)按所有权归属分类
  归属于母公司股东的净利润(元) -146,415,660.11-52,739,278.5718,605,574.69-223,768,564.38-48,558,678.78-40,568,261.28-57,654,813.97
  少数股东损益(元) -401,302.74-484,074.01-340,238.22-551,549.62-323,914.75-399,526.13-722,239.74
 扣除非经常性损益后的净利润(元) -129,697,597.80-81,680,855.30-24,692,107.75-208,564,267.41-76,185,909.91-47,188,146.7817,413,546.31
七、每股收益
 一、基本每股收益(元) -0.16-0.060.02-0.26-0.05-0.05-0.06
 二、稀释每股收益(元) -0.16-0.060.02-0.26-0.05-0.05-0.06
八、其他综合收益(元) -569,955.084,978,308.36-1,230,539.09-2,652,260.095,793,552.435,489,815.10-406,694.89
 归属于母公司股东的其他综合收益(元) -569,955.084,978,308.36-1,230,539.09-2,652,260.095,793,552.435,489,815.10-406,694.89
九、综合收益总额(元) -147,386,917.93-48,245,044.2217,034,797.38-226,972,374.09-43,089,041.10-35,477,972.31-58,783,748.60
 归属于母公司所有者的综合收益总额(元) -146,985,615.19-47,760,970.2117,375,035.60-226,420,824.47-42,765,126.35-35,078,446.18-58,061,508.86
 归属于少数股东的综合收益总额(元) -401,302.74-484,074.01-340,238.22-551,549.62-323,914.75-399,526.13-722,239.74
公告日期 2023-10-302023-08-152023-04-272023-04-272022-10-292022-08-272022-04-28
审计意见(境内) 标准无保留意见

前瞻产业研究院